Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Clinical trial NCT02539459 · TERMINATED
Trial details
- NCT number
- NCT02539459
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-23
- Primary completion
- 2018-08-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.